CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Buprenorphinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000205
NCT00000205Phase 3Completed
CompareCT.gov

Buprenorphine Maintenance Protocol

University of California, Los Angeles·interventional·Posted Sep 21, 1999·Updated Jul 11, 2016

In Brief

A Phase 3 clinical trial evaluating Buprenorphine for Opioid-Related Disorders. Completed, across 1 site.

Detailed Summary

The purpose of this study is to compare the efficacy of buprenorphine versus methadone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-Related Disorders
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 3CompletedFinished
19901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 21, 1999
Enrollment StartOct 1, 1990
Primary CompletionMar 1, 1993
Study CompletionSep 1, 1993
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 26.8 years ago

Interventions

Buprenorphinedrug